The phase 3 PEGASUS trial found that patients with paroxysmal nocturnal hemoglobinuria (PNH) may still experience anemia following recommended therapies, underscoring the need for further research. In ...

Scandinavian Real Heart today announced a new in vitro study backs its Realheart total artificial heart (TAH) system.

red blood cells The FDA has granted Priority Review for the Biologics License Application (BLA) for sutimlimab for the treatment of hemolysis in adult patients with cold agglutinin disease, a rare ...

Researchers have used supercomputers to model how red blood cells deform and become damaged in mechanical circulatory support devices, such as blood pumps used for heart failure patients. The study ...

Voydeya is a first-in-class, oral, factor D inhibitor. The Food and Drug Administration (FDA) has approved Voydeya ™ (danicopan) as add-on therapy to ravulizumab or eculizumab for the treatment of ...

Hemolysis is the #1 source of preanalytical error and can impact potassium results—potentially leading to inappropriate or delayed patient treatment, unnecessary ...

"Our previous work showed that SARS-CoV-2 spike proteins lead to complement dysregulation by binding heparan sulfate and disrupting complement factor H…This doesn’t happen on red cells because red ...

Scandinavian Real Heart AB (publ) announces today that a new in vitro study, published in the peer-reviewed journal Artificial Organs, demonstrates that the Realheart® TAH causes approximately half ...

CHRONIC lymphocytic leukemia and malignant lymphomas of the lymphocytic and follicular types may be relatively prolonged, benign diseases. They are inevitably fatal, however, and the final years are ...

THE sequence of hemoglobinuria followed by oliguria and anuria is well known. The observations reported below are especially concerned with the medical management of the anuric patient and with the ...

Delayed immune hemolysis is an uncommon, but serious complication of HSC transplantation. Pretransplant clinical consideration is usually given only to ABO and Rh compatibility between the donor and ...